Inhibitory effects of GL-V9 on the invasion of human breast carcinoma cells by downregulating the expression and activity of matrix metalloproteinase-2/9.

[1]  M. Shokrgozar,et al.  Inhibition of silibinin on migration and adhesion capacity of human highly metastatic breast cancer cell line, MDA-MB-231, by evaluation of β1-integrin and downstream molecules, Cdc42, Raf-1 and D4GDI , 2012, Medical Oncology.

[2]  N. Lu,et al.  Oroxylin A inhibits matrix metalloproteinase-2/9 expression and activation by up-regulating tissue inhibitor of metalloproteinase-2 and suppressing the ERK1/2 signaling pathway. , 2012, Toxicology letters.

[3]  N. Lu,et al.  Inhibitory effects of wogonin on the invasion of human breast carcinoma cells by downregulating the expression and activity of matrix metalloproteinase-9. , 2011, Toxicology.

[4]  Qin Xu,et al.  Inhibiting adenoid cystic carcinoma cells growth and metastasis by blocking the expression of ADAM 10 using RNA interference , 2010, Journal of Translational Medicine.

[5]  J. Gu,et al.  Wnt/β-Catenin Signaling Down-regulates N-Acetylglucosaminyltransferase III Expression , 2010, The Journal of Biological Chemistry.

[6]  D. Ma,et al.  Plexin-B1 silencing inhibits ovarian cancer cell migration and invasion , 2010, BMC Cancer.

[7]  N. Lu,et al.  Flavonoid baicalein suppresses adhesion, migration and invasion of MDA-MB-231 human breast cancer cells. , 2010, Cancer letters.

[8]  Z. Werb,et al.  Matrix Metalloproteinases: Regulators of the Tumor Microenvironment , 2010, Cell.

[9]  A. Kong,et al.  Metabolism, oral bioavailability and pharmacokinetics of chemopreventive kaempferol in rats. , 2009, Biopharmaceutics & drug disposition.

[10]  S. K. Park,et al.  Kalopanaxsaponin A inhibits PMA-induced invasion by reducing matrix metalloproteinase-9 via PI3K/Akt- and PKCdelta-mediated signaling in MCF-7 human breast cancer cells. , 2009, Carcinogenesis.

[11]  Ssang-Goo Cho,et al.  Downregulation of PLK-1 expression in kaempferol-induced apoptosis of MCF-7 cells. , 2009, European journal of pharmacology.

[12]  Q. Qi,et al.  Wogonoside inhibits lipopolysaccharide-induced angiogenesis in vitro and in vivo via toll-like receptor 4 signal transduction. , 2009, Toxicology.

[13]  W. Ahn,et al.  Kaempferol induced the apoptosis via cell cycle arrest in human breast cancer MDA-MB-453 cells , 2008, Nutrition research and practice.

[14]  Ling-mei Wang,et al.  Quercetin inhibition of tumor invasion via suppressing PKC delta/ERK/AP-1-dependent matrix metalloproteinase-9 activation in breast carcinoma cells. , 2008, Carcinogenesis.

[15]  Jie Zhao,et al.  Inhibition of alpha(4) integrin mediated adhesion was involved in the reduction of B16-F10 melanoma cells lung colonization in C57BL/6 mice treated with gambogic acid. , 2008, European journal of pharmacology.

[16]  H. Randeva,et al.  Visfatin induces human endothelial VEGF and MMP-2/9 production via MAPK and PI3K/Akt signalling pathways: novel insights into visfatin-induced angiogenesis. , 2008, Cardiovascular research.

[17]  I. Kostova,et al.  Antiangiogenic effects of flavonoids and chalcones. , 2008, Pharmacological research.

[18]  Gerhard Christofori,et al.  Distinct mechanisms of tumor invasion and metastasis. , 2007, Trends in molecular medicine.

[19]  Yan Wang,et al.  Inhibitory effects of resistin-13-peptide on the proliferation, adhesion, and invasion of MDA-MB-231 in human breast carcinoma cells. , 2007, Endocrine-related cancer.

[20]  L. March,et al.  Differential regulation of matrix metalloproteinase 2 and matrix metalloproteinase 9 by activated protein C: relevance to inflammation in rheumatoid arthritis. , 2007, Arthritis and rheumatism.

[21]  S. Leivonen,et al.  EGF‐R regulates MMP function in fibroblasts through MAPK and AP‐1 pathways , 2007, Journal of cellular physiology.

[22]  A. Moon,et al.  TGF-β-induced transcriptional activation of MMP-2 is mediated by activating transcription factor (ATF)2 in human breast epithelial cells , 2007 .

[23]  D. Edwards,et al.  Progestin effects on breast cancer cell proliferation, proteases activation, and in vivo development of metastatic phenotype all depend on progesterone receptor capacity to activate cytoplasmic signaling pathways. , 2007, Molecular endocrinology.

[24]  In-Seon Lee,et al.  Silibinin suppresses PMA-induced MMP-9 expression by blocking the AP-1 activation via MAPK signaling pathways in MCF-7 human breast carcinoma cells. , 2007, Biochemical and biophysical research communications.

[25]  P. Bischof,et al.  Involvement of MAPK pathway in TNF-α-induced MMP-9 expression in human trophoblastic cells , 2006 .

[26]  J. Quigley,et al.  Matrix metalloproteinases and tumor metastasis , 2006, Cancer and Metastasis Reviews.

[27]  J. Hyun,et al.  Curcumin suppresses phorbol ester-induced matrix metalloproteinase-9 expression by inhibiting the PKC to MAPK signaling pathways in human astroglioma cells. , 2005, Biochemical and biophysical research communications.

[28]  Young-Chae Chang,et al.  Ascochlorin Inhibits Matrix Metalloproteinase-9 Expression by Suppressing Activator Protein-1-mediated Gene Expression through the ERK1/2 Signaling Pathway , 2005, Journal of Biological Chemistry.

[29]  S. Duthie,et al.  The effect of short-term kaempferol exposure on reactive oxygen levels and integrity of human (HL-60) leukaemic cells. , 2005, Biochimica et biophysica acta.

[30]  Christoph Weiler,et al.  Cell density-dependent regulation of matrix metalloproteinase and TIMP expression in differently tumorigenic breast cancer cell lines. , 2005, Experimental cell research.

[31]  P. Angel,et al.  AP-1 subunits: quarrel and harmony among siblings , 2004, Journal of Cell Science.

[32]  Eun-sook Kim,et al.  TGF-beta-induced upregulation of MMP-2 and MMP-9 depends on p38 MAPK, but not ERK signaling in MCF10A human breast epithelial cells. , 2004, International journal of oncology.

[33]  Zhonglin Xie,et al.  Differential Regulation of Matrix Metalloproteinase-2 and -9 Expression and Activity in Adult Rat Cardiac Fibroblasts in Response to Interleukin-1β* , 2004, Journal of Biological Chemistry.

[34]  W. Young,et al.  Minocycline Exerts Multiple Inhibitory Effects on Vascular Endothelial Growth Factor–Induced Smooth Muscle Cell Migration: The Role of ERK1/2, PI3K, and Matrix Metalloproteinases , 2004, Circulation research.

[35]  Young-ho Kim,et al.  Resveratrol inhibits phorbol myristate acetate-induced matrix metalloproteinase-9 expression by inhibiting JNK and PKC δ signal transduction , 2004, Oncogene.

[36]  Cheorl-Ho Kim,et al.  ERK1/2 mediates TNF‐α‐induced matrix metalloproteinase‐9 expression in human vascular smooth muscle cells via the regulation of NF‐κB and AP‐1: Involvement of the ras dependent pathway , 2004, Journal of cellular physiology.

[37]  Huynh Hung,et al.  Inhibition of estrogen receptor alpha expression and function in MCF‐7 cells by kaempferol , 2004, Journal of cellular physiology.

[38]  K. Lee,et al.  Imbalance between matrix metalloproteinase‐9 and tissue inhibitor of metalloproteinase‐1 in toluene diisocyanate‐induced asthma , 2004, Clinical and experimental allergy : journal of the British Society for Allergy and Clinical Immunology.

[39]  F. Oakley,et al.  Induction of myofibroblast MMP-9 transcription in three-dimensional collagen I gel cultures: regulation by NF-kappaB, AP-1 and Sp1. , 2004, The international journal of biochemistry & cell biology.

[40]  E. Wagner,et al.  AP-1: a double-edged sword in tumorigenesis , 2003, Nature Reviews Cancer.

[41]  Sanjeev Banerjee,et al.  Ursolic Acid Inhibits Nuclear Factor-κB Activation Induced by Carcinogenic Agents through Suppression of IκBα Kinase and p65 Phosphorylation: Correlation with Down-Regulation of Cyclooxygenase 2, Matrix Metalloproteinase 9, and Cyclin D1 , 2003 .

[42]  J. Abbruzzese,et al.  Stat3 activation regulates the expression of vascular endothelial growth factor and human pancreatic cancer angiogenesis and metastasis , 2003, Oncogene.

[43]  B. Havsteen,et al.  The biochemistry and medical significance of the flavonoids. , 2002, Pharmacology & therapeutics.

[44]  C. Sawyers,et al.  The phosphatidylinositol 3-Kinase–AKT pathway in human cancer , 2002, Nature Reviews Cancer.

[45]  M. Crépin,et al.  FGF-2 and TPA induce matrix metalloproteinase-9 secretion in MCF-7 cells through PKC activation of the Ras/ERK pathway. , 2002, Biochemical and biophysical research communications.

[46]  Z. Werb,et al.  The many faces of metalloproteases: cell growth, invasion, angiogenesis and metastasis. , 2001, Trends in cell biology.

[47]  Li Yan,et al.  The High Molecular Weight Urinary Matrix Metalloproteinase (MMP) Activity Is a Complex of Gelatinase B/MMP-9 and Neutrophil Gelatinase-associated Lipocalin (NGAL) , 2001, The Journal of Biological Chemistry.

[48]  S. Zucker,et al.  Matrix metalloproteinases in cancer invasion, metastasis and angiogenesis. , 2001, Drug discovery today.

[49]  I. Stamenkovic.  Matrix metalloproteinases in tumor invasion and metastasis. , 2000, Seminars in cancer biology.

[50]  N. Colburn,et al.  Activator protein 1 (AP-1)– and nuclear factor κB (NF-κB)–dependent transcriptional events in carcinogenesis , 2000 .

[51]  M. Duffy,et al.  Increased gelatinase‐A and gelatinase‐B activities in malignant vs. benign breast tumors , 2000, International journal of cancer.

[52]  L. Matrisian,et al.  Matrix metalloproteinases: multifunctional contributors to tumor progression. , 2000, Molecular medicine today.

[53]  D. Crowe,et al.  Transcriptional inhibition of matrix metalloproteinase 9 (MMP-9) activity by a c-fos/estrogen receptor fusion protein is mediated by the proximal AP-1 site of the MMP-9 promoter and correlates with reduced tumor cell invasion. , 1999, Neoplasia.

[54]  J. Westermarck,et al.  Regulation of matrix metalloproteinase expression in tumor invasion , 1999, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.

[55]  A. Albini,et al.  Tumor and endothelial cell invasion of basement membranes. The matrigel chemoinvasion assay as a tool for dissecting molecular mechanisms. , 1998, Pathology oncology research : POR.

[56]  F. Kikkawa,et al.  c‐Ras is required for the activation of the matrix metalloproteinases by concanavalin A in 3Y1 cells , 1997, FEBS letters.

[57]  E. Zandi,et al.  AP-1 function and regulation. , 1997, Current opinion in cell biology.

[58]  R. Fridman,et al.  Epidermal growth factor and amphiregulin up‐regulate matrix metalloproteinase‐9 (MMP‐9) in human breast cancer cells , 1997, International journal of cancer.

[59]  James P. Quigley,et al.  Matrix Metalloproteinase-2 Is an Interstitial Collagenase , 1995, The Journal of Biological Chemistry.

[60]  S. Gruber,et al.  Direct evidence linking expression of matrix metalloproteinase 9 (92-kDa gelatinase/collagenase) to the metastatic phenotype in transformed rat embryo cells. , 1994, Proceedings of the National Academy of Sciences of the United States of America.

[61]  R. Huber,et al.  The X‐ray crystal structure of the catalytic domain of human neutrophil collagenase inhibited by a substrate analogue reveals the essentials for catalysis and specificity. , 1994, The EMBO journal.

[62]  Y Nishizuka,et al.  Protein kinase C as a possible receptor protein of tumor-promoting phorbol esters. , 1983, The Journal of biological chemistry.

[63]  I. Fidler,et al.  Metastasis results from preexisting variant cells within a malignant tumor. , 1977, Science.

[64]  A. Jemal,et al.  Global cancer statistics , 2011, CA: a cancer journal for clinicians.

[65]  Yi-Chen Liao,et al.  Nobiletin, a citrus flavonoid, suppresses invasion and migration involving FAK/PI3K/Akt and small GTPase signals in human gastric adenocarcinoma AGS cells , 2010, Molecular and Cellular Biochemistry.

[66]  N. Lu,et al.  LYG-202, a newly synthesized flavonoid, exhibits potent anti-angiogenic activity in vitro and in vivo. , 2010, Journal of pharmacological sciences.

[67]  Do-Hee Kim,et al.  15-Deoxy-Delta12,14-prostaglandin J2 induces COX-2 expression through Akt-driven AP-1 activation in human breast cancer cells: a potential role of ROS. , 2008, Carcinogenesis.

[68]  S. Zucker,et al.  Role of matrix metalloproteinases (MMPs) in colorectal cancer , 2004, Cancer and Metastasis Reviews.

[69]  T. Gress,et al.  Invasion and metastasis in pancreatic cancer. , 1999, Annals of oncology : official journal of the European Society for Medical Oncology.

[70]  H. Birkedal‐Hansen,et al.  Matrix metalloproteinases: a review. , 1993, Critical reviews in oral biology and medicine : an official publication of the American Association of Oral Biologists.